S1PR1 and hepatocellular carcinoma: The results showed that W146 inhibited the expression of S1PR1 in EC (Fig. 8A), and W146 also reduced the promotion of migration and tube formation in EC induced by HCC supernatant (Fig. 8B, C), indicating that W146 might be a potential antiangiogenic drug targeting S1PR1 for HCC treatment.